111 related articles for article (PubMed ID: 8815641)
41. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
42. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
[TBL] [Abstract][Full Text] [Related]
43. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
Madani I; Bonte K; Vakaet L; Boterberg T; De Neve W
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):424-32. PubMed ID: 18755554
[TBL] [Abstract][Full Text] [Related]
44. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
Bachar G; Goldstein DP; Shah M; Tandon A; Ringash J; Pond G; Gullane PJ; Perez-Ordonez B; Gilbert RW; Brown DH; Gentili F; O'Sullivan B; Irish JC
Head Neck; 2008 Dec; 30(12):1607-14. PubMed ID: 18798301
[TBL] [Abstract][Full Text] [Related]
45. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
Adelstein DJ; Rice TW; Becker M; Larto MA; Kirby TJ; Koka A; Tefft M; Zuccaro G
Cancer; 1997 Sep; 80(6):1011-20. PubMed ID: 9305700
[TBL] [Abstract][Full Text] [Related]
46. [Cancer of the nasal cavity].
Hu WH; Xie FY; Fang SH; Jiao JJ; Yan C; Peng WJ; Fu XY; Zhang F
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):117-21. PubMed ID: 15946555
[TBL] [Abstract][Full Text] [Related]
47. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
Homma A; Oridate N; Suzuki F; Taki S; Asano T; Yoshida D; Onimaru R; Nishioka T; Shirato H; Fukuda S
Cancer; 2009 Oct; 115(20):4705-14. PubMed ID: 19634162
[TBL] [Abstract][Full Text] [Related]
48. [Peripheral blood indices in preoperative radiotherapy (using radiomodifiers) of lung cancer].
Demidchik IuE; Zharkov VV; Prokhorova VI; Rubanova VZ
Med Radiol (Mosk); 1989 Sep; 34(9):49-52. PubMed ID: 2796643
[No Abstract] [Full Text] [Related]
49. [Clinical experiences with the use of metronidazole in the radiotherapy of cancer patients].
Cyb AF; Chmelevskaja ZI; Kudrjavceva GT
Radiobiol Radiother (Berl); 1985; 26(3):339-42. PubMed ID: 4059519
[No Abstract] [Full Text] [Related]
50. [Long term result of radiotherapy of carcinoma of the nasal cavity--report on 62 cases].
Wang JB
Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):55-7. PubMed ID: 3979254
[No Abstract] [Full Text] [Related]
51. [The hemostatic homeostasis of patients with malignant neoplasms of the larynx, stomach and uterine cervix during radiotherapy and radiosensitization with metronidazole].
Cekalina SI; Berdov BA; Guseva LI
Radiobiol Radiother (Berl); 1990; 31(6):523-9. PubMed ID: 2101457
[TBL] [Abstract][Full Text] [Related]
52. [Use of radiomodifiers during radiotherapy of patients with malignant tumors].
Kiseleva ES; Dar'ialova SL; Kvasov VA; Pitskhelauri VG; Sukirko VA
Med Radiol (Mosk); 1986 Feb; 31(2):17-21. PubMed ID: 3951343
[TBL] [Abstract][Full Text] [Related]
53. [Use of electron acceptor compounds in radiotherapy].
Tsyb AF; Konopliannikov AG; Kudriavtseva GT
Med Radiol (Mosk); 1983 Jul; 28(7):26-9. PubMed ID: 6348457
[TBL] [Abstract][Full Text] [Related]
54. [The radiation therapy of malignant tumors of the maxillofacial area and its outlook (a review of the literature)].
Vorob'ev IuI
Stomatologiia (Mosk); 1993; 72(1):75-7. PubMed ID: 8048111
[No Abstract] [Full Text] [Related]
55. [Modification of radiosensitivity in maignant and normal tissues during radiotherapy of malignant neoplasms].
Neklasova NY; Zharinov GM; Grebenyuk AN
Radiats Biol Radioecol; 2014; 54(6):597-605. PubMed ID: 25980286
[TBL] [Abstract][Full Text] [Related]
56. [Results of combined therapy for malignant tumors of the nasal cavity and accessory nasal sinus depending on the fractionation of preoperative radiotherapy].
Vdovina SN; Andreev VG; Gulibov IA; Pankratov VA; Rozhnov VA; Baryshev VV; Buiakova ME; Litovkina LV
Vopr Onkol; 2006; 52(2):196-9. PubMed ID: 17195648
[TBL] [Abstract][Full Text] [Related]
57. [Long-term follow-up results of chemotherapy of tumors localized in otolaryngologic region in combination with surgical and x-ray therapy].
Uchytil B; Mechl Z
Cesk Otolaryngol; 1971 Jun; 20(3):120-4. PubMed ID: 5564733
[No Abstract] [Full Text] [Related]
58. [Therapeutic results in malignant jaw tumors during the years 1960-1964].
Gebhart J; Schlegel D
Med Monatsschr; 1969 May; 23(5):218-26. PubMed ID: 5801880
[No Abstract] [Full Text] [Related]
59. [Increasing the metronidazole content of tumors using pyrogenal hyperthermia].
Efimov ML; Koposova RP; Seĭtkazina GD; Vasil'eva GS; Kovalenko VR
Med Radiol (Mosk); 1987 Nov; 32(11):67-8. PubMed ID: 3683129
[No Abstract] [Full Text] [Related]
60. [Postradiogenic effect in liver tissue of patients with stomach cancer after radiosensitization with metronidazole].
Djakova AM; Stefani NV; Zagrebin VM; Senokosov NI; Berdov BA
Radiobiol Radiother (Berl); 1985; 26(3):343-50. PubMed ID: 4059520
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
